| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871877 | The Annals of Thoracic Surgery | 2015 | 7 Pages |
Abstract
Interleukin-6 is significantly greater in both murine and human TAA compared with AAA, suggesting fundamental differences in these disease processes. Interleukin-6 receptor antagonism attenuates experimental TAA formation, indicating that IL-6 may be a potential target for human thoracic aneurysmal disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Nicolas H. MD, Morgan PhD, William F. MD, Guanyi MD, PhD, Christine L. MD, Gilbert R. MD, Gorav MD,